FDA Expands Use of Breast Cancer Drug to Men FDA Expands Use of Breast Cancer Drug to Men

The agency extended the indication of the advanced breast cancer drug palbociclib (Ibrance, Pfizer) to include male patients.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news